RiverFront Investment Group’s Gilead Sciences GILD Stock Holding History

RiverFront Investment Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$500K	Buy	3,589 +142	+4%	+$19.9K	0.01%	261
2025 Q4	$423K	Sell	3,447 -291	-8%	-$35.4K	0.01%	250
2025 Q3	$415K	Buy	+3,738	New	+$425K	0.01%	232
2025 Q2	–	Sell	-1,924	Closed	-$216K	–	320
2025 Q1	$216K	Buy	+1,924	New	+$199K	﹤0.01%	270
2021 Q3	–	Sell	-3,649	Closed	-$251K	–	106
2021 Q2	$251K	Buy	3,649 +138	+4%	+$9.21K	0.01%	123
2021 Q1	$227K	Buy	+3,511	New	+$226K	﹤0.01%	113

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

RiverFront Investment Group's GILD Position: Q1 2026 in Review

RiverFront Investment Group increased its Gilead Sciences (GILD) stake by 4.1% in Q1 2026, buying an estimated $19.9K and bringing the position to 3,589 shares worth $500K. The position accounts for 0.01% of the portfolio, ranked #261.

RiverFront Investment Group first reported a position in GILD in Q1 2021 and has held it in 6 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

RiverFront Investment Group held 3,589 shares of Gilead Sciences worth $500K as of Q1 2026.
RiverFront Investment Group bought 142 Gilead Sciences shares in Q1 2026, an estimated $19.9K.
Gilead Sciences made up 0.01% of RiverFront Investment Group's portfolio in Q1 2026, its #261 holding.
RiverFront Investment Group first reported a position in Gilead Sciences in Q1 2021 and has held it in 6 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on RiverFront Investment Group's 13F filing for Q1 2026, filed 11 May 2026.